2.08 USD
↗ 0.01 (0.48%)AT CLOSE (11:59 AM EDT)
Alaunos Therapeutics, Inc. Common Stock
TCRTNASDAQ • USD
2.40
↗ 0.32 (15.58%)
POST MARKET (AS OF 07:43 PM EDT)
Post Market
AS OF 07:43 PM EDT
2.40
↗ 0.32 (15.58%)
Market: CLOSED
Shares of Alaunos Therapeutics, Inc. Common Stock (TCRT) are trading at $2.08. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 26, 2026.
Open?$2.07
High?$2.23
Low?$2.06
Prev. Close?$2.07
Volume?14.0K
Avg. Volume?17.7K
VWAP?$2.15
Rel. Volume?0.79x
Bid / Ask
Bid?$1.78 × 100
Ask?$2.47 × 100
Spread?$0.69
Midpoint?$2.13
Valuation & Ratios
Market Cap?5.1M
Shares Out?24.4M
Float?1.9M
Float %?77.7%
P/E Ratio?N/A
P/B Ratio?3.94
EPS?-$1.79
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
Address
501 E LAS OLAS BLVD
FORT LAUDERDALE, FL 33301
Phone: (346) 355-4099
FORT LAUDERDALE, FL 33301
Phone: (346) 355-4099
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?80
Piotroski F-Score?0/9Weak
Altman Z-Score?-690.10Distress
Confidence?40%Low
Short InterestLow
Short % of Float?0.62%Low
Short Interest?11.6K
Days to Cover?1.0
Free Float1.9M
Avg Daily Volume21.8K
Settlement Date2026-06-15
Financial Health
Current Ratio?1.63Adequate
Quick Ratio?1.63Adequate
Cash Ratio?0.59Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?3.94FAIR▾
Peers100
S&P45
P/S?1,693.22HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.1CHEAP▾
S&P97
EV/Sales?1,575.22HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-338.8%WEAK▾
S&P3
ROA?-231.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-3226000
Enterprise Value?$4.7M
Fundamentals ratios updated end of day